S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE‐RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST‐LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE‐CELL LYMPHOMA
Wang, M. L., Jurczak, W., Jerkeman, M., Trotman, J., Zinani, P. L., Belada, D., Boccomini, C., Flinn, I. W., Giri, P., Goy, A., Hamlin, P. A., Hermine, O., Hernández‐Rivas, J.‐Á., Hong, X., Kim, S. J., Lewis, D., Mishima, Y., Özcan, M., Perini, G. F., Pocock, C., Song, Y., Spurgeon, S. E., Storring, J. M., Walewski, J., Zhu, J., Qin, R., Henninger, T., Deshpande, S., Howes, A., Le Gouill, S., Dreyling, M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article